Showing results (71-80 of 119) with videos related to
Sort By:
Pageof 12
Cancer Research|August 17, 2000
Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapyR J Knox, T C Jenkins, S M Hobbs, et al.The American Journal of Medicine|August 1, 1986
Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemiaJ E Karp, J D Dick, C Angelopulos, et al.Journal of the National Cancer Institute|December 19, 1990
Effects of the differentiating agent hexamethylene bisacetamide on normal and myelodysplastic hematopoietic progenitorsE K Rowinsky, R C Donehower, J L Spivak, et al.Archives of Dermatology|November 1, 1989
Cutaneous eruptions of lymphocyte recoveryT D Horn, J V Redd, J E Karp, et al.Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Design and synthesis of novel pyrrolobenzodiazepine (PBD) prodrugs for ADEPT and GDEPTM J Sagnou, P W Howard, S J Gregson, et al.Cancer Genetics and Cytogenetics|February 1, 1996
Derivative (6)t(1;6)(q22;p21) revealed in bone marrow cells by FISH 9 months before diagnosis of acute T-lymphoblastic leukemiaK Michalová, P Lemez, O Bartsch, et al.Journal of Medicinal Chemistry|March 26, 1999
Novel inhibitors of carboxypeptidase G2 (CPG2): potential use in antibody-directed enzyme prodrug therapyT H Khan, E A Eno-Amooquaye, F Searle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1995
Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemiaS D Gore, L J Weng, R J Jones, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|May 1, 1989
Ophthalmic manifestations of leukemiaA P Schachat, J A Markowitz, D R Guyer, et al.Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.Pageof 12